1. Home
  2. APAM vs MIRM Comparison

APAM vs MIRM Comparison

Compare APAM & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APAM
  • MIRM
  • Stock Information
  • Founded
  • APAM 1994
  • MIRM 2018
  • Country
  • APAM United States
  • MIRM United States
  • Employees
  • APAM N/A
  • MIRM N/A
  • Industry
  • APAM Investment Managers
  • MIRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • APAM Finance
  • MIRM Health Care
  • Exchange
  • APAM Nasdaq
  • MIRM Nasdaq
  • Market Cap
  • APAM 2.9B
  • MIRM 2.5B
  • IPO Year
  • APAM 2013
  • MIRM 2019
  • Fundamental
  • Price
  • APAM $46.32
  • MIRM $53.77
  • Analyst Decision
  • APAM Hold
  • MIRM Strong Buy
  • Analyst Count
  • APAM 6
  • MIRM 9
  • Target Price
  • APAM $43.42
  • MIRM $66.22
  • AVG Volume (30 Days)
  • APAM 611.3K
  • MIRM 354.1K
  • Earning Date
  • APAM 07-29-2025
  • MIRM 08-06-2025
  • Dividend Yield
  • APAM 7.64%
  • MIRM N/A
  • EPS Growth
  • APAM 12.91
  • MIRM N/A
  • EPS
  • APAM 3.78
  • MIRM N/A
  • Revenue
  • APAM $1,136,529,000.00
  • MIRM $379,251,000.00
  • Revenue This Year
  • APAM $6.76
  • MIRM $36.76
  • Revenue Next Year
  • APAM $8.17
  • MIRM $17.48
  • P/E Ratio
  • APAM $12.24
  • MIRM N/A
  • Revenue Growth
  • APAM 10.03
  • MIRM 69.31
  • 52 Week Low
  • APAM $32.75
  • MIRM $36.86
  • 52 Week High
  • APAM $49.54
  • MIRM $54.78
  • Technical
  • Relative Strength Index (RSI)
  • APAM 54.79
  • MIRM 46.89
  • Support Level
  • APAM $43.59
  • MIRM $50.70
  • Resistance Level
  • APAM $46.93
  • MIRM $52.74
  • Average True Range (ATR)
  • APAM 1.13
  • MIRM 1.43
  • MACD
  • APAM -0.13
  • MIRM -0.26
  • Stochastic Oscillator
  • APAM 78.07
  • MIRM 15.59

About APAM Artisan Partners Asset Management Inc.

Artisan Partners Asset Management Inc is a global investment management firm providing a range of investment strategies to a diverse group of clients around the world. Each of the company's strategies is managed by one of its several investment teams. Investment management services are primarily offered to institutions through separate accounts and mutual funds. Artisan's investment offerings include several long-only, equity investment strategies across a multitude of market capitalization segments and investing styles in both the United States and international markets. In addition to its equity strategies, customers may invest in a fixed-income strategy. Strategies are often distributed to customers ranging from retail investors to institutional investors through specialized channels.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: